Single-Nucleotide Polymorphisms, PITX2 and Abnormal Electrical Activity in Atrial Fibrillation
International Journal of Molecular Sciences · 08.10.2025 · 26 (19) · 9780
DOI: 10.3390/ijms26199780 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.10.2025. Verfasst von Verónica Jiménez-Sábado und 1 weiteren Autor:innen. Beteiligte Einrichtung: CIBER de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, 28029 Madrid, Spain. Hauptthemen laut MEDLINE: Atrial Fibrillation, Polymorphism, Single Nucleotide, Transcription Factors, Homeodomain Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Spanish Ministry of Science, Innovation and Universities.
Abstract (Originalsprache)
Since single-nucleotide polymorphisms (SNPs) associated with increased risk of atrial fibrillation (AF) on chromosome 4q25 are located near the transcription factor PITX2, research has investigated relationships between SNPs, PITX2 activity and atrial function to improve risk stratification and identify new therapies. Although PITX2 levels are heterogeneous, most studies converge towards lower PITX2 levels in patients with AF, and a 4q25 SNP has been reported to reduce PITX2 expression. However, there are several SNPs at 4q25 that segregate independently, and patients carrying different SNPs respond differently to ablation therapy. On the other hand, atrial-specific deletion of Pitx2c mimics molecular and electrophysiological alterations observed in patients with AF. This includes microRNAs, signaling pathways, ion channels, calcium homeostasis, electrical remodeling, contraction and the response to pharmacological treatments. Moreover, mutations in the PITX2 homeodomain are associated with AF, PITX2 dysfunction or impaired calcium homeostasis. Interestingly, myocytes with the 4q25 risk allele rs13143308T display electrophysiological alterations similar to those reported in patients with AF or mice with heterozygous Pitx2c deletion. Moreover, carriers of rs13143308T respond poorly to ablation or antiarrhythmic drug therapy. Future research needs to establish how different 4q25 SNPs impact different PITX2 isoforms and the downstream regulation of atrial function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CIBER de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Institut de Recerca Sant Pau (IR SANT PAU), 08041 Barcelona, Spain.
- Instituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas (IIBB-CSIC), 08036 Barcelona, Spain.
ORCID-Profile: Verónica Jiménez-Sábado, Leif Hove-Madsen
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- Spanish Ministry of Science, Innovation and Universities
Zitieren
APA
Jiménez-Sábado, V., & Hove-Madsen, L. (2025). Single-Nucleotide Polymorphisms, PITX2 and Abnormal Electrical Activity in Atrial Fibrillation. International Journal of Molecular Sciences, 26(19), 9780. https://doi.org/10.3390/ijms26199780
Vancouver
Jiménez-Sábado V, Hove-Madsen L. Single-Nucleotide Polymorphisms, PITX2 and Abnormal Electrical Activity in Atrial Fibrillation. International Journal of Molecular Sciences. 2025;26(19):9780. doi:10.3390/ijms26199780
BibTeX
@article{JimnezSbado2025,
author = {Jiménez-Sábado, Verónica and Hove-Madsen, Leif},
title = {Single-Nucleotide Polymorphisms, PITX2 and Abnormal Electrical Activity in Atrial Fibrillation},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9780},
doi = {10.3390/ijms26199780}
}
EUVIMED